Top 20 Biopharma Deal Terminations of 2021 Based on Total Deal Value

Shots: The biopharma industry saw numerous deal terminations in 2021. Clinical and regulatory results, change of control limitations, and strategic reprioritizations were among the most common reasons for deal termination. SOBI and Advent's acquisition agreement in 2021 ranked first under which Advent International offered to acquire SOBI. The second position goes to Galapagos’ development and…

ByPrince GiriMarch 10, 2022

TOP 20

Top 20 Life Sciences Deals of 2021 by Total Deal Value

Shots: The life science industry saw high deal activity in 2021 staying in the range of an even busier 2020. Fourth-quarter 2021 set the tone with Recursion’s development and commercialization deal with Roche and Genentech for a total value of $12.7B, followed by Poseida Therapeutics’ development and commercialization deal with Takeda for $3.73B. This article is based on the 2021…

ByPrince GiriFebruary 10, 2022

TOP 20

Top 20 Biopharma M&A of 2021 by Total Deal Value

Shots: Biopharma merger and acquisition activity continued under the radar with smaller deals through 2021. Despite the absence of eagerly-awaited mega-merger, there were a number of deals above $1 billion. CSL Limited holds the top rank by acquiring Vifor Pharma among the top 20 acquisitions with a total deal value of $11.7B. CSL adds 10…

ByPrince GiriJanuary 20, 2022

TOP 20

TOP 20 Animal Health Companies of 2020 by Total Revenue

Humans depends on livestock for survival and Animal Health has always been an issue to look for since it directly reflects the betterment of human life For a country’s economy and balanced human life, proper care and disease-free health of animals play a key role. Since rapid environmental change has targeted animal health, it becomes…

ByPrince GiriDecember 23, 2021

TOP 20

Top 20 Generics Pharma Companies Based On 2020 Revenue

Shots: Generic medicines are the backbone of the healthcare system and are identical to the innovator medicine in strength- effect- dosage form- and route of administration. These are allowed for sale after the patent expiry of the original drugs Our team at PharmaShots has compiled a list of the top 20 generic companies based on…

ByPrince GiriOctober 28, 2021

TOP 20

Top 20 Oncology Companies Based on 2020 Oncology Segment Revenue

Oncology is a rapidly evolving therapy area and all of the top Biopharma players are investing in the research and development of cancer therapies. In 2020- the world witnessed a major acquisition of Immunomedic by Gilead of $21B for Trodelvy Our team at PharmaShots has compiled a list of top 20 oncology companies based on…

ByPrince GiriSeptember 9, 2021

TOP 20

Top 20 Immunology Companies Based on 2020 Immunology Segment Revenue

Immunology deals with the physiological functioning of the immune system in states of both health and disease as well as malfunctions of the immune system in immunological disorders With the new advancement in the immune sector- global pharmaceuticals continue to grow in the field despite the disruption during COVID-19. As in 2019- Abbvie again secured…

ByPrince GiriAugust 12, 2021

TOP 20

Top 20 Innovative Digital Therapeutics Companies of 2020

The digital therapeutics market has unsurprisingly exploded in last few years. Available virtually- digital therapies are developed by engineers- clinicians & scientists and are rigorously tested- making it possible for people to access treatment for both physical & psychological conditions at home Demand for digital therapies has skyrocketed amid the COVID-19 pandemic. As a result-…

ByPrince GiriJuly 8, 2021

TOP 20

Top 20 Diagnostics Companies Based on 2020 Revenue

The extraordinary demand for COVID-19 testing kits that were seen in 2020 and is yet to subside in 2021 resulted in many of the world's biggest diagnostics companies being thrust into the limelight Siemens Healthineers- GE Healthcare- Roche- and Abbott are the top players in the race of the global diagnostic companies. The companies are…

ByPrince GiriJune 10, 2021

TOP 20

Top 20 Medical Device Companies Based on 2020 Revenue

The medical devices industry is a fast-growing market driven by the complex needs of patients encouraging life science companies to develop innovative therapies to improve health and QoL In 2020- the companies have shown growth resulting from a rise in the number of healthcare facilities- healthcare expenditure- and technological advancements. Medtronic remains at the top…

ByPrince GiriMay 20, 2021

Prince Giri

Top 20 Biopharma Deal Terminations of 2021 Based on Total Deal Value

Top 20 Life Sciences Deals of 2021 by Total Deal Value

Top 20 Biopharma M&A of 2021 by Total Deal Value

TOP 20 Animal Health Companies of 2020 by Total Revenue

Top 20 Generics Pharma Companies Based On 2020 Revenue

Top 20 Oncology Companies Based on 2020 Oncology Segment Revenue

Top 20 Immunology Companies Based on 2020 Immunology Segment Revenue

Top 20 Innovative Digital Therapeutics Companies of 2020

Top 20 Diagnostics Companies Based on 2020 Revenue

Top 20 Medical Device Companies Based on 2020 Revenue

Contact US

OUR INFORMATION

FOLLOW US